Two Sigma Investments
PMVP icon

Two Sigma Investments’s PMV Pharmaceuticals PMVP Stock Holding History

Two Sigma Investments’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.34M Buy
1,884,530
+1,178,469
+167% +$1.5M ﹤0.01% 2637
2025
Q4 		$883K Buy
706,061
+436,440
+162% +$585K ﹤0.01% 3007
2025
Q3 		$377K Sell
269,621
-21,834
-7% -$30.2K ﹤0.01% 3117
2025
Q2 		$309K Sell
291,455
-61,772
-17% -$60.6K ﹤0.01% 2782
2025
Q1 		$385K Sell
353,227
-153,759
-30% -$209K ﹤0.01% 2624
2024
Q4 		$766K Buy
506,986
+23,931
+5% +$37.9K ﹤0.01% 2331
2024
Q3 		$720K Buy
483,055
+94,747
+24% +$146K ﹤0.01% 2294
2024
Q2 		$629K Sell
388,308
-11,402
-3% -$20.6K ﹤0.01% 2250
2024
Q1 		$680K Buy
399,710
+121,009
+43% +$226K ﹤0.01% 2184
2023
Q4 		$864K Buy
278,701
+244,630
+718% +$647K ﹤0.01% 2162
2023
Q3 		$209K Sell
34,071
-25,944
-43% -$178K ﹤0.01% 2626
2023
Q2 		$376K Sell
60,015
-76,935
-56% -$403K ﹤0.01% 2441
2023
Q1 		$653K Buy
136,950
+122,950
+878% +$865K ﹤0.01% 2086
2022
Q4 		$122K Sell
14,000
-14,400
-51% -$153K ﹤0.01% 2482
2022
Q3 		$338K Buy
+28,400
New +$410K ﹤0.01% 1926
2022
Q2 		– Sell
-44,900
Closed -$935K – 2847
2022
Q1 		$935K Sell
44,900
-226,646
-83% -$4M ﹤0.01% 1732
2021
Q4 		$6.27M Buy
271,546
+257,046
+1,773% +$6.21M 0.01% 1063
2021
Q3 		$432K Buy
+14,500
New +$463K ﹤0.01% 3381

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments's PMVP Position: Q1 2026 in Review

Two Sigma Investments increased its PMV Pharmaceuticals (PMVP) stake by 167% in Q1 2026, buying an estimated $1.5M and bringing the position to 1,884,530 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

Two Sigma Investments first reported a position in PMVP in Q3 2021 and has held it in 18 quarters since. The position peaked at $6.27M in Q4 2021. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Two Sigma Investments held 1,884,530 shares of PMV Pharmaceuticals worth $2.34M as of Q1 2026.
  • Two Sigma Investments bought 1,178,469 PMV Pharmaceuticals shares in Q1 2026, an estimated $1.5M.
  • PMV Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2637 holding.
  • Two Sigma Investments first reported a position in PMV Pharmaceuticals in Q3 2021 and has held it in 18 quarters since.
  • Two Sigma Investments's PMV Pharmaceuticals position peaked at $6.27M in Q4 2021.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.